News FDA delays decision on abuse deterrence data on Endo painkil... Data could be used to fend off generic competition.
News Branded pharma condemns UK generic price hiking Newspaper investigation reveals small number of companies hiking the prices of generic drugs.
News Novartis sheds MorphoSys staff, sites after pelabresib delay Novartis has confirmed it will shut down two MorphoSys sites in Germany and the US, with the loss of around 330 jobs, by the end of next year.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
